MedPath

Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans

Early Phase 1
Completed
Conditions
Obesity
Diabetes
NAFLD (Nonalcoholic Fatty Liver Disease)
Registration Number
NCT06681597
Brief Summary

To investigate the molecular mechanism of raspberry ketone on regulating obesity, the investigators studied the effect of raspberry ketone intake on FGF21 in plasma.

The age of the volunteers were 18-60 years old, both male and female, without diabetes, hypertension and other diseases.

After ingestion of raspberry ketone (500mg), 2ml of blood was collected at 0 hours, 3 hours and 6 hours , and the FGF21 content in plasma was measured using a commercial reagent kit.

In addition, the investigators also studied the effect of raspberry ketone intake on energy metabolism 0 hours, 0.5 hours, 3 hours and 6 hours after consuming raspberry ketone (500mg).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

No drugs were taken before the human study

Exclusion Criteria

Patients with hypertension

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Impact of raspberry ketone consumption on plasma FGF21 levelThrough study completion, an average of 1 year
Impact of raspberry ketone consumption on energy expenditureThrough study completion, an average of 1 year

The oxygen consumption, heart rate, carbon dioxide production were measured

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath